Highlights

  • At the same time, the company is short of cash and waiting on assays from its main Brazilian prospect.
  • According to its September quarter activities report dated 30 October 2026, its key project is East Salinas in Minas Gerais.
  • At Naked Hill, the company reported 68 holes for about 1,469 metres, including diamond and auger holes.
  • At the ASX minimum price step, an unchanged quote may simply be a stale last trade.

Enova Mining Limited (ASX:ENV) is changing the structure of its share register while it pays for rare earths exploration in Brazil. On 4 November 2026 it notified the ASX of a 25-for-1 share consolidation. That followed a Placement and a rights issue, both priced at AUD 0.001 per share. The consolidation was put to shareholders at a general meeting on 13 November 2026.

For anyone following the stock, the practical point is that the share count and quoted price are about to be reset.

What Enova does

Enova explores for rare earth elements (REE), mainly in Brazil. That project contains the Naked Hill, Bald Hill, Hairy Hill and Flat Hill prospects, where it is targeting ionic adsorption clay (IAC) mineralisation. Its other projects are Poços de Caldas and Santo António do Jacinto in Brazil and Charley Creek in the Northern Territory. It also holds an option over the Caraúbas monazite project in Paraíba.

The company is at the exploration stage. Its report states there has been insufficient exploration to define a Mineral Resource at its projects.

Exploration progress

It expected assays and leach test results from mid-November 2026. Leach tests on six saprolite samples from Poços de Caldas recovered between 66% and 79% of the neodymium-praseodymium (NdPr), or 71% on average.

At Charley Creek, one hole returned 12 metres at 1,400 ppm total rare earth oxides (TREO) from 32 metres. These are exploration results, not resources, and leach tests on a few samples do not show a process works at scale.

On 14 October 2026 Enova extended Due Diligence on Caraúbas to 1 December 2026. Exercising the option needs satisfactory due diligence and Shareholder approval, so completion is not certain.

Funding and dilution

It estimated only about 0.6 quarters of funding, so the company had to answer the ASX's going-concern questions.

The first AUD 297,000 Tranche was completed, and the remaining AUD 1.703 million needed shareholder approval. A one-for-four non-renounceable rights issue closed on 30 October. On 4 November the company reported acceptances of only about 19%, raising about AUD 94,800, which left a shortfall of about AUD 400,000. The board kept the right to place the shortfall.

An addendum dated 30 October cut the consolidation ratio from 50:1 to 25:1. The ASX notice gave 24 November as the last day of pre-consolidation trading, with post-consolidation trading from 25 November, subject to approval. It said shares on issue would fall from about 2.28 billion to about 91.1 million.

Risks

The main risks are financing and execution: low cash, heavy dilution from issues at a tenth of a cent, and dependence on assay results. Rare earth prices and permitting add uncertainty.

Share Trading on 16 November

Its Market Value was about AUD 4.16 million. The figures predate the consolidation.